Coronaviruses (CoVs) are important human pathogens with significant zoonotic potential.
Introduction
The majority of human coronaviruses (CoVs) cause mild disease phenotypes. However, when novel coronaviruses like severe acute respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV emerge from their animal reservoirs to infect humans they elicit a robust and aberrant immune response that can lead to a very serious and deadly pneumonia (1) (2) (3) . Importantly, there are no effective vaccines or therapeutics to treat these CoVs. Efforts to develop long-term therapeutic strategies to combat novel, highly pathogenic CoVs will be aided by increased understanding of conserved viral mechanisms at the level of their cell and molecular biology.
One of the more fascinating and relatively enigmatic aspects of CoV biology is that CoV virions bud into the lumen of the secretory pathway at the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) , and then must navigate through the Golgi and the anterograde endomembrane system to be efficiently released from the host cell. It has been demonstrated that the structure and function of the Golgi depends upon an acidic pH gradient that decreases from the lumen of the cis-Golgi to the lumen of the trans-Golgi. This pH gradient is produced by a balance maintained by proton influx into the lumen of the Golgi, proton leak, and counter-ion conductance (4) . Pharmacological manipulations of the pH gradient, resulting in neutralization of the lumen, have all been shown to cause slow trafficking of cargo through the Golgi as well as alteration in Golgi morphology (4) (5) (6) (7) (8) (9) (10) . A class of small viral membrane proteins with ion channel activity, called viroporins, have been shown to have dramatic effects on the secretory pathway, similar to those elicited by pharmacological manipulation of luminal pH (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) .Several well-studied members of this viroporin family of proteins include the Influenza A M2 protein (IAV M2), hepatitis C virus (HCV) p7 protein, and the CoV envelope (E) protein. These representative viroporins demonstrate several common functional features despite differences in viral assembly and budding locations. It has been suggested the role of M2 in the secretory pathway is to neutralize luminal pH to protect the HA fusion protein of influenza from premature activation (5) (6) (7) . Overexpression of M2 causes secretory pathway disruption where the rate of intracellular trafficking is slowed and Golgi morphology is altered (8) . HCV p7 is also thought to play a protective role by allowing egress of viral structural proteins through the secretory pathway. HCV can be partially rescued by both pharmacological neutralization of the luminal spaces by bafilomycin A1 and by in trans expression of IAV M2 (9, 10) . Similar to M2, the infectious bronchitis virus (IBV) coronavirus E protein elicits multiple secretory pathway disruption phenotypes when overexpressed in mammalian cells.
To understand CoV E at a cell biological level, a recombinant virus system was used to replace the hydrophobic domain (HD) of IBV E with the HD of the vesicular stomatitis virus glycoprotein (VSV G), and the recombinant virus was called IBV EG3 (22, 23) . Replacing the HD of IBV E with a heterologous sequence of the same length does not impair Golgi targeting or interaction with IBV M during assembly (24, 25) , but would be expected to impair ion channel function. One-step growth curves revealed that IBV EG3 virus grew to a titer 10-fold lower than IBV WT virus in infected Vero cells. At late times post-infection, the majority of infectious virus resides in the supernatant surrounding IBV WT infected cells, while the majority of infectious IBV EG3 virus is intracellular (23) . Vero cells infected with IBV EG3 accumulate more IBV S protein on the plasma membrane than IBV WT infected cells and this accumulation of IBV S leads to an increase in the size and rate of formation of the virus-induced syncytia (23) . Most virions purified from IBV EG3 infected cells lack a full complement of spikes and S is aberrantly cleaved near the virion envelope, potentially explaining the reduced infectivity of released particles (22) . A build-up of vacuole-like compartments containing virions as well as other aberrant material in IBV EG3 infected cells may explain the damage to S (22, 23) . Intriguingly, when IBV WT E is transiently overexpressed in HeLa cells, the Golgi completely disassembles while the Golgi in cells overexpressing IBV EG3 is intact (23) . This observation suggested that IBV E alters the secretory pathway of the host cell. Expression of IBV E or EG3 reduces trafficking rates of both membrane and secretory cargo (23) . Given that release of infectious IBV EG3 is reduced, it was surprising that wild-type E protein reduced cargo trafficking. It was hypothesized that since the HD was required, alteration of the lumen by E ion channel activity was required for maintaining intact virus, and the reduced rates of trafficking were an acceptable compromise for the virus.
Studies probing the nature of CoV E ion channel activity have centered on understanding the residues required for this activity and the associated pathogenic and cell biological phenotypes elicited by different CoV E proteins. Two residues in the HD of SARS-CoV E, N15 and V25, have been shown to promote viral fitness during infection (11, 21) .
Mutation of N15 or V25 abolishes ion-channel activity of SARS-CoV E in artificial membranes (11, 21) . We previously reported that the E protein of IBV is expressed in mammalian cells is found in two pools by velocity gradient analysis: a low molecular weight pool (LMW) and a high molecular weight pool (HMW) (26) . The LMW pool represents IBV E in a monomeric state while the HMW pool correlates with a homo-oligomer of IBV E. When mutations corresponding to the conserved HD residues of SARS-CoV E that inhibit ion channel activity were made in IBV E (T16A and A26F), we found that the HD mutants segregated primarily into one oligomeric pool or the other. The E T16A mutant was primarily in the HMW pool while the E A26F mutant was found primarily in the LMW pool. The presence of the LMW pool of IBV E, the predominant and likely monomeric form found when E A26F is present, correlates with the secretory pathway disruption associated with the WT IBV E protein (26) . This was surprising in that it suggested an E ion channel-independent role for IBV E associated with manipulation of the secretory pathway. It was recently reported that that these HD mutants do abolish ion channel activity of IBV E in artificial membranes, and virus titers are reduced by a log in the supernatant of infected cells, suggesting a defect in virion release (27) . Our data on the IBV-EG3 virus corroborates this study (23) .
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Herein, we provide evidence for the neutralization of the Golgi during IBV infection and we demonstrate that transient over-expression of the IBV E protein, but not HD mutants deficient in the LMW pool of IBV E, is sufficient to cause a significant increase in the pH of the Golgi lumen. We suggest that increased trafficking and aberrant cleavage of the IBV S protein observed during IBV EG3 infection may reflect the detrimental effect of normal pH on IBV S processing. We demonstrate that IBV S processing and trafficking is similarly aberrant when coexpressed with EG3 but not WT E, and that IAV M2 can substitute for WT E to protect S from premature cleavage.
Results

IBV induces an increase in Golgi luminal pH during infection.
Given that the effects of IBV E overexpression on the Golgi are similar to those in cells where the luminal pH is neutralized, we first measured luminal pH in IBV-infected cells. We used flow cytometric analysis of a ratiometric pHluorin molecule targeted to the Golgi with a reporter consisting of the green fluorescent protein (GFP) pHluorin molecule fused to the membrane targeting sequence of the TGN38 trans-Golgi network resident protein (28) . We chose to use the trans-Golgi network pHluorin because the TGN is the most acidic compartment of the Golgi and thus any alteration in pH would likely be most detectable in this compartment. We generated a clonal Vero cell line that stably expressed the TGN38-pHluorin ( Figure 1A ). The generation of this cell line allowed us to ensure that all infected cells were expressing the TGN38-pHluorin. The cells were treated with cycloheximide for 60 minutes to chase newly synthesized TGN38-pHluorin from the ER. To generate a pH calibration curve, cells expressing the Golgi pHluorin molecule were subjected to treatment with buffers ranging from pH 5.5 to 7.5 in the presence of the ionophores monensin and nigericin prior to flow analysis ( Figure 1B ). The emission ratios of the biphasic pH-sensitive pHluorin at these known pH values can then be used to predict the Golgi luminal pH in cells infected with IBV in buffer at physiological pH and lacking ionophores ( Figure 1C ). Infection resulted in a robust increase in the Golgi luminal pH.
We attempted to measure the Golgi luminal pH in cells infected with IBV-EG3, but were unable to achieve a high percent of infected cells in the absence of syncytium formation, since this virus is not efficiently released and spreads best by cell-cell fusion. We found that syncytia were fragile, and this precluded flow cytometric analysis. Instead we turned to transfected cells to determine if the E protein could neutralize the Golgi lumen.
Overexpression of the IBV E protein increases the pH of the Golgi lumen.
To determine if the pH change in infected cells was caused by the E protein, HeLa cells were cotransfected with a plasmid encoding IBV E along with the pHlorin-TGN38 reporter. We used transient transfection of the reporter here to ensure the pHluorin expressing cells were also expressing the E protein. In separate cells, we included vector alone and a plasmid encoding IBV M (as another overexpressed Golgi membrane protein) as controls. As described above, transfected cells were pretreated with cycloheximde for 60 min to chase newly synthesized pHlorin-TGN38 out of the ER. A standard curve was produced in cells treated with ionophores in calibrated pH buffers. As shown in Figs 2B and C, IBV E neutralized the trans-Golgi luminal pH when over expressed in HeLa cells, whereas the IBV M protein did not.
The increase in Golgi pH correlates with the LMW pool of IBV E.
To determine the role of IBV E oligomerization in the alteration of Golgi luminal pH, we analyzed two HD point mutants of IBV E that segregate into different oligomeric states. Our previous findings suggest that IBV E A26F is found predominantly in the LMW, likely monomeric form, and IBV E T16A is found predominantly in the HMW, higher-order oligomer (26) . In addition, we analyzed the EG3 mutant of IBV E, in which the entire HD of IBV E was replaced by a heterologous HD sequence. Both IBV E T16A and IBV EG3 had pH measurements similar to the IBV M membrane protein control (pH 6.95 and pH 6.87, respectively), while IBV E A26F elicited a robust pH increase similar to that of the wild-type IBV E protein (pH 7.18, Figure 3A .) This suggested that the LMW pool of IBV E correlates with the luminal pH increase of the Golgi in addition to the secretory pathway disruption demonstrated in our previous work (23, 26, 29) . The same experiment was performed with a medial-Golgi pHluorin, GnT1-pHluorin (Gnt1, N-acetylglucosaminyltransferase I), to assess if the alteration in pH was specific to the TGN. Indeed, both IBV E and IBV E A26F elicited a robust pH increase ( Figure 3B ). Interesting, IBV E T16A increased the pH significantly, though not as robustly as IBV E and IBV E A26F . We found that the pH of the trans-Golgi (measured with TGN38-pHluorin) was higher than the medial-Golgi (measured with GnT1-pHluorin). This was unexpected and is addressed in the discussion. The results in transfected cells implicate the monomeric form of IBV E in neutralization of the Golgi lumen during infection and transfection.
Attempts to rescue IBV EG3 by manipulation of Golgi pH. Despite intense efforts we were unable to conclusively determine whether an increase in Golgi pH could rescue the deficiencies of the IBV EG3 virus. We tried drugs that neutralize acidic compartments (baflinomycin A1, monensin and ammonium chloride), as well as overexpression of influenza A M2, a pH activated proton channel (4). However, the drugs inhibited exocytosis at all concentrations used (during short or long infections), and, we were unable to obtain a high percentage of M2transfected cells that were subsequently infected with IBV-EG3. In several experiments where the percent of transfected and infected cells was greater than 40%, we obtained 40-75% increases in release of infectious IBV-EG3 virus, but most experiments failed to show a reasonable overlap of transfection and infection and rescue of IBV-EG3 infectivity (data not shown). Additionally, attempts to make stable lines expressing M2 and pHluorin did not yield lines expressing M2 at a high enough level to alter the Golgi pH. We thus turned to another approach to assess the role of neutralization of the Golgi by IBV E during infection.
Expression of IAV M2 decreases the total amount cleaved IBV S species in cells and at
the cell surface. The IBV S protein is cleaved by a furin-like protease generating the S1 and S2 subunits during trafficking through the Golgi, and at a second site (S2') that primes the protein for fusion with the host cell (30) .The S protein of IBV-EG3 is subject to further proteolysis near the junction of the protein with the viral envelope, resulting in a C-terminal fragment we term the 'stub' (22) . We predicted that neutralization of Golgi pH by IBV E during infection protects the IBV S protein from premature proteolysis at the normal acidic pH of the trans-Golgi. We also As predicted there was a significant increase in the total amount of IBV S at the surface of EG3 expressing cells as compared to WT IBV E. Notably, the presence of M2 in EG3 expressing cells reduced the amount IBV S at the surface of cells to a level comparable to cells expressing WT IBV E ( Figure 5B. ). Additionally, the total amounts of cleaved IBV S species (S2, S2', and stub) were significantly increased in cell lysates expressing EG3 when compared to WT IBV E, and the presence of M2 in EG3 expressing cells reduced the amount of cleaved IBV S species back to levels comparable with cells expressing WT IBV E ( Figure 5C ). The same trend toward increased IBV S cleavage in EG3 expressing cells and a reduction in the cleaved species in the presence of M2 were also observed at the cell surface, though the differences were not significant. suggested the pH increase may be physiologically important. Our baseline measurement of pH 6.78 in the context of transient overexpression of the TGN38-pHluorin and IBV E protein in HeLa cells, and the baseline of 6.76 in the context of Vero cells stably expressing the TGN38-pHluorin are both similar, though somewhat higher, than pH values reported in the literature for the TGN. Values for the TGN38-pHluorin in different cell types range from pH 6.2-6.7 (28, 31, 32) . We believe that the slightly higher baseline measurement we observed is likely due to some plasma membrane cycling of the TGN38-pHluorin, which would increase the average pH in a given cell since the pH of the extra cellular buffer was pH 7.3. The cycling of TGN38-pHlorin is likely to be the predominant reason for a higher than expected TGN pH, since the medial-Golgi pHluorin reported a pH of ~6.4. We believe that the consistent shift in the Golgi pH in cells expressing IBV E is more important than the actual baseline pH value we observed with the TGN38-pHlorin. Previously, the TGN38-pHluorin construct was used to demonstrate that CHO cells lacking the counter-ion channel Golgi pH regulator (GPHR) had a 0.4 pH unit increase, which substantiates the magnitude of the observed pH increase in this study. However, the IBV E T16A or IBV EG3 HD mutants did not cause a statistically significant shift (0.20 and 0.12 pH units, respectively). We previously showed that the LMW pool of IBV E correlates with the secretory pathway disruption, including Golgi disassembly and slow trafficking of model cargo proteins, observed when the wild-type IBV E protein is expressed (23, 29) . We hypothesized that the Golgi disruption was likely occurring in an IBV E ion channelindependent manner (26, 29) . This study corroborates our hypothesis and suggests that the monomeric form of IBV E causes Golgi disruption via alteration of Golgi luminal pH through a mechanism involving interaction with a host protein. This interpretation is strengthened by evidence suggesting that neither the IBV E T16A or IBV E A26F mutants have ion channel activity in artificial membranes (27) , suggesting that any remaining HMW weight, oligomeric IBV E that may be present when IBV E A26F is expressed is not likely eliciting secretory pathway disruption or pH neutralization via IBV E ion channel activity. However, To et al. suggest that mutation of IBV E T16A and not IBV E A26F prevents oligomerization of IBV E, the opposite of our findings. The difference in these results is likely due to different modes of protein expression and the downstream assays used to evaluate oligomerization. In our studies we expressed the HD mutants in mammalian cells and evaluated oligomerization via sucrose gradient analysis followed by cross-linking and immunoprecipitation of gradient fractions of interest (26). To et al.
Discussion
Neutralization of
bacterially expressed these proteins and then analyzed them via native PAGE electrophoresis after purifying and resolubilizing the samples (27) .
Neutralization of Golgi luminal pH by IBV E and IAV M2 correlates with reduced cleavage of IBV S protein.
A proposed model for the cleavage and function of CoV S proteins suggests that proteolytic processing at two cleavage sites (S1/S2 and S2') releases the protein from its prefusion conformation and allows for a conformational change that exposes the fusion peptide (33) . This change in conformation may also release the S1 subunits from The S2 subunits of the CoV S trimer (33) . A possible detrimental consequence of the normal acidic Golgi pH to the virus could be that the S protein is subject to a conformational change and premature and possibly excessive proteolytic processing, resulting in release of the S1 subunit prior to receptor binding. This would result in noninfectious or impaired virions. Here we demonstrate that when IBV S is overexpressed in cells in the presence of EG3, the levels of IBV S cleavage species are increased significantly as compared to IBV S in the presence of IBV E or IAV M2, lending support to the hypothesis that the neutralization of Golgi pH by IBV E protects IBV S from premature cleavage. Additionally, when over expressed in cells IBV S is present to a greater extent at the cell surface, corroborating previous data observed during IBV EG3 infection (23) .
CoV E protein viroporins and protein interaction.
What is striking about IBV E when compared to M2 or p7 is the notion that IBV E is likely causing secretory pathway disruption in an IBV E ion-channel independent way. If IBV E is acting as a monomer to elicit secretory pathway disruption and alter pH, interaction of IBV E with a host protein(s) or lipid(s) would be necessary.
Evidence suggests that CoV E proteins interact with host cell proteins to influence pathogenicity. Interaction of SARS-CoV E with the PDZ (post-synaptic density protein-95/discs Large/zonula occludens-1) domain containing scaffolding protein, syntenin, and with the tight junction protein PALS1 (protein associated with Lin Seven 1) through its PBM (PDZ-binding motif) domain, implicates the E protein as a pathogenic determinant (34) (35) (36) (37) (38) (39) . The importance of the SARS-CoV E PBM domain was made more evident in studies addressing SARS-CoV infection with viruses lacking the E protein (40) . During passage in tissue culture viruses lacking the E gene incorporated a partial duplication of the M gene in which novel and variable PBM domains were incorporated into the chimeric M gene (40) . Similarly, deletion of the E gene in recombinant MHV has also been shown to result in partial duplication of M gene (41) . When Plasmids. The pCAGSS IBV E, IBV EG3, IBV M, IBV E T16A , IBV E A26F , codon optimized IBV S, M2 and empty pCAGGS-MCS plasmids have been previously described (23, 29, (46) (47) (48) (49) . The pCAGGS M2 plasmid was a generous gift from Dr. Andrew Pekosz. The pME-zeo-pHluorin-TGN38 plasmid and GnT1-pHluorin plasmids have been previously described and were generous gifts from Dr. Yusuke Maeda (28) .
Transient transfection. X-tremeGENE 9 DNA Transfection Reagent (Roche, Indianapolis, IN) was used to transiently transfect cells according to the manufacturer's protocol. Subconfluent HeLa cells in 6 mm dishes were transfected with 1 µg of each plasmid indicated for a particular experiment, diluted into Opti-MEM (Invitrogen/Gibco) with a 1:3 ratio of X-tremeGENE 9. When the TGN38-pHluorin plasmid was transfected alone the pCAGGS-MCS empty vector was transfected to control for the total amount of DNA transfected. For the cotransfection of IBV S with E, EG3 and IAV M2, subconfluent Vero cells in 6 well dishes were transfected with a total of 2 ug of DNA: 1 ug of pCAGGS/IBV S plus 0.5 ug pCAGGS/IBV E or EG3, and 0.5 ug pCAGGS/MCS or pCAGGS/IAV M2 as described above.
Antibodies. The rabbit polyclonal antibodies recognizing the C-terminus of IBV E and the Nterminal head of golgin-160 have been previously described (50, 51) . The antibody generated to the C-terminus of IBV S has also been described (52) .The mouse monoclonal antibody recognizing the N-terminus of influenza A M2 has been previously described and was a generous gift from Dr. Andrew Pekosz (53). The mouse anti-GFP antibody was from Roche (Mannheim, Germany). The rabbit anti-GFP antibody was from Thermo Fisher Scientific (Rockford, IL). Alexa-Fluor 488-conjugated anti-rabbit IgG, Alexa-Fluor 488-conjugated antimouse IgG, Alexa Fluor 568-conjugated anti-rabbit IgG, and Alexa Fluor 568-conjugated antimouse IgG were from Invitrogen/Molecular Probes (Eugene, OR).
Indirect immunofluorescence microscopy. Cells were washed with PBS and fixed in 3% paraformaldehyde in PBS for 10 min at 22˚C. The fixative was quenched in PBS containing 10 mM glycine (PBS-Gly), and the cells were permeabilized in 0.5% Triton X-100 for 3 min. The coverslips were washed twice with PBS-Gly and incubated in primary antibody with 1% BSA for 20 min at room temperature. Rabbit anti-IBV E and rabbit anti-golgin160 were used at 1:1,000.
Rabbit anti-GFP and mouse anti-M2 were used at 1:500. Mouse anti-GFP was used at 1:300.
The cells were then washed twice with PBS-Gly and incubated for 20 min in secondary antibody with 1% BSA. Alexa-Fluor 488-conjugated anti-rabbit IgG and Alexa Fluor 568-conjugated antimouse IgG were used at 1:1,000. The coverslips were washed twice in PBS-Gly and incubated with Hoescht 33285 [0.1 µg/ml] to stain DNA, rinsed twice in PBS-Gly and mounted on slides in glycerol containing 0.1M N-propylgallate. Images were captured using an Axioskop microscope (Zeiss) equipped for epifluorescence with an ORCA-03G charge-coupled-device camera (Hamamatsu, Japan) and iVision software (Bio Vision Technologies). Streptavidin-agarose beads (50 ul of a 50% slurry, Pierce) were added and samples were incubated for 2h at 4 o C and 30 min at 22 o C. The beads were washed twice in NHN and eluted in 2x sample buffer with 5% -mercaptoethanol at 85 o C for 5 min. Samples were electrophoresed in NUPAGE 4-12% gradient gels (ThermoFisher) and transferred to low fluorescence PVDF (Millipore). After blocking in 10 mM Tris-HCl pH 7,4, 0.15 M NaCl (TBS) plus 5% nonfat milk, membranes were probed with rabbit anti-IBV S diluted 1:5000 in TBS/0.05% Tween (TBS/Tw).
Establishment of TGN38-pHluorin stable
Bands were detected with donkey anti-rabbit IgG-680 (LI-COR) diluted in TBS/Tw, and imaged using the LI-COR Odyssey CLx. Quantification was performed in Image Studio (LI-COR), and each IBV S fragment was expressed as the percent of the total S for both the input and surface fractions.
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